Sight Sciences

Visit our booth this Saturday from 11:15 AM to 12:00 PM to see the OMNI? Surgical System in action in various cases across the spectrum of glaucoma disease severity.?Don’t miss this opportunity to gain valuable insights and tips from Zarmeena Vendal, MD, and Matthew Brink, MD, and enhance your skills and understanding of MIGS and the OMNI procedure! See more information about our AAO activities at www.sightsciences.com/aao

“These results really underscore OMNI’s ability for long-term intraocular pressure reduction and medication?reduction?and proving its efficacy that it’s not just short-term results but really long-term results lasting for 3 years,” said Noureen Khan, MD, of Northern Virginia Ophthalmology Associates about the 36-month results from the GEMINI study she presented at the Women in Ophthalmology meeting. Watch the full video to learn more about OMNI’s 36-month results: https://lnkd.in/eDmhWgz4 . . . . . . . . . . The OMNI? Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. Dr.?Noureen Khan?is a paid consultant of Sight Sciences. Correction: The proportion of patients at 12M who had IOP between 6-18 mmHg was 76%, not 80% as stated in the video. OM-3280-US.v1 #omnisurgical?#glaucoma?#migs?#wio2024?#ophthalmology #eyecare #ophthalmologists

Patients should have insured access to interventional therapy for MGD and doctors should receive fair reimbursement for that therapy. Unfortunately, that’s not the reality today— but Sight Sciences is investing in making this change happen. Join us at AAO, booth 4019, to learn more. www.sightsciences.com/aao www.tearcare.com ?

Join us at AAO in booth 4019 for an interactive clearance experience with your peers and learn the latest on Sight Sciences’ commitment to securing fair access for interventional MGD therapy. www.sightsciences.com/aao

Join us at AAO in Chicago, booth 4019, from October 19 to 21 for an exciting lineup of activities, including OMNI and SION demonstrations, case presentations, learning skills labs, TearCare? Clearance Experiences, clinical collaborations, and reimbursement discussions. We look forward to seeing you soon! See a list of our activities at AAO at www.sightsciences.com/aao

Love your eyes, protect your sight! Today, on World Sight Day (October 10), we join the global effort to raise awareness about eye health and inspire people to take care of their vision. At Sight Sciences, our mission is to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing. Learn more about World Sight Day here: https://lnkd.in/eNGA4Dz3 #WorldSightDay #WorldSightDay2024 #LoveYourEyes #KeepSeeing

Greetings from Berlin and Southampton! Our German team (first photo) is representing us at the DOG Congress in Berlin, while our UK team (second photo) is at the UKEGS meeting in Southampton. Both teams are sharing insights on how our OMNI technology is transforming MIGS and advancing the interventional mindset in eyecare!

We had a fantastic and productive time at #ASCRS2024 earlier this year, connecting with colleagues, customers, and industry friends.?Now, we are excited to welcome you to our booth at #AAO2024 in Chicago from October 19-21!?Join us for an engaging lineup of activities, including live demos, presentations, learning labs, clinical collaborations, and reimbursement discussions. We hope to see you there! Learn more at?https://lnkd.in/gNfTKRdw

Thank you, Dr. Avneet Sodhi Gaur and Dr. Douglas McGraw, for visiting us today and spending time with our R&D team. It’s always a pleasure to collaborate and drive innovation forward together!

Congratulations to Dr. Clarke Nelson, Dr. Tommy Dang, Dr. Regis Rumpf, and Dr. Judd Cahoon on completing the clinical and surgical training for the OMNI? Surgical System! We are honored to partner with these outstanding surgeons and excited to welcome them and their teams to the Sight Sciences family. Together, we are reimagining eyecare with transformative technology and an interventional mindset. Thank you for your partnership—we look forward to continued success together! ? Clarke Nelson, MD, PhD Katzen Eye Group Lutherville, MD ? Tommy Dang, MD Mid-Atlantic Eye Care Williamsburg, VA ? Regis Rumpf, MD North Park Ophthalmology Pittsburgh, PA ? Judd Cahoon, MD, PhD Astorino & Associates Eye Center Newport Beach, CA We also thank our colleagues—Alana Woodard, Chris Anderson, Chris Faith, Carrie McMullin, Justyn Stormes—for their dedication in helping eyecare providers to procedurally elevate the standards of care! Contact your local Sight Sciences rep to learn more about our?training?programs. ? . . . . . . . . . . The OMNI? Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit www.sightsciences.com/omni for more information and the indications for use, contraindications, warnings, and potential adverse events. #omnisurgical #migs #glaucoma #ophthalmology #omnicertification